Kawasumi Laboratories America, Inc. Awarded Healthtrust Purchasing Trust (HPG) Safety Blood Collection Contract
Tampa, FL, October 03, 2013 --(PR.com)-- Kawasumi Laboratories America, Inc. (KLA) announced today that it has been awarded the Safety Blood Collection contract with the Group Purchasing Organization Healthtrust Purchasing Group (HPG). HPG contract 6027 has been awarded as a multi-source contract with two other manufacturers.
KLA has four safety products on the contract including the K-Shield Advantage winged blood collection set available with and without a pre-attached tube holder.
It is estimated that there are more than 600,000 accidental needle sticks in medical settings yearly in the United States. According to the website www.needle-stick-syringe-injury.com, the CDC estimates that 62 to 88 percent of sharps injuries can potentially be prevented by the use of safer medical devices. Needle Stick and other sharps-related injuries that result in occupational blood borne pathogens exposure continue to be an important public health concern. Use of safety needle devices is required by Rule 1910.1030 of the Occupational Safety and Health Administration’s Needlestick Safety and Prevention Act of 2000. Federal and state fines in the thousands of dollars can be levied for violations of needlestick safety standards.
Kawasumi Laboratories America, Inc.’s K-Shield® Advantage is designed to eliminate accidental needlestick injuries suffered by nurses and other medical practitioners by allowing them to safely, easily cover the needle in a protective sheath with a one handed technique as it is withdrawn from the patient.
Additionally, the practitioner can still use the standard two-handed technique if they prefer, so there is no need for additional in-service training in how to use the K-Shield® Advantage. This design feature sets the K-Shield® Advantage apart from the competition.
Truly OSHA Compliant
Providing the K-Shield® Advantage for use by medical practitioners brings employers into compliance with the requirements of Rule 1910.1030 of the Occupational Safety and Health Administration’s Needlestick Safety and Prevention Act of 2000.
“Some similar products claim they are in full OSHA compliance, while they are not,” said Kirstie Wilson, KLA’s Marketing Manager.
“And, because of the increasing incidence of accidental needle sticks, 21 U.S. states now have laws on the books providing for state sanctions and fines for non-compliance with federal and state rules regulating occupational exposure to blood borne pathogens,” said Wilson. “User safety was the guiding principle in development of the unique K-Shield® Advantage design.”
While the U.S. Centers for Disease Control and Prevention estimate some 800,000 accidental needlestick injuries occur in the U.S. annually, the medical forum www.needlestick.com puts the number at between 600,000 and 1 million annually.
“If these numbers are to be cut substantially, clearly there is a dire need for all facilities that draw blood to require awareness of the availability of ultra-modern needlestick prevention technology for all staff,” commented Wilson.
About Kawasumi Laboratories America
Kawasumi Laboratories America, Inc. (KLA) is a wholly owned subsidiary of Kawasumi Laboratories, Inc.(KL), headquartered in Tokyo, Japan. KL have been providing high quality, cost-effective, medical supplies worldwide since 1957.
Located in Tampa, FL, KLA is the main distribution center for both North and South America. KLA was incorporated in 1991, and recently relocated to a larger facility. KLA is dedicated to maintaining the quality and standards set by the parent company.
Media Contact: Kirstie Wilson
Marketing Manager
813-630-5554 ext. 224
KLA has four safety products on the contract including the K-Shield Advantage winged blood collection set available with and without a pre-attached tube holder.
It is estimated that there are more than 600,000 accidental needle sticks in medical settings yearly in the United States. According to the website www.needle-stick-syringe-injury.com, the CDC estimates that 62 to 88 percent of sharps injuries can potentially be prevented by the use of safer medical devices. Needle Stick and other sharps-related injuries that result in occupational blood borne pathogens exposure continue to be an important public health concern. Use of safety needle devices is required by Rule 1910.1030 of the Occupational Safety and Health Administration’s Needlestick Safety and Prevention Act of 2000. Federal and state fines in the thousands of dollars can be levied for violations of needlestick safety standards.
Kawasumi Laboratories America, Inc.’s K-Shield® Advantage is designed to eliminate accidental needlestick injuries suffered by nurses and other medical practitioners by allowing them to safely, easily cover the needle in a protective sheath with a one handed technique as it is withdrawn from the patient.
Additionally, the practitioner can still use the standard two-handed technique if they prefer, so there is no need for additional in-service training in how to use the K-Shield® Advantage. This design feature sets the K-Shield® Advantage apart from the competition.
Truly OSHA Compliant
Providing the K-Shield® Advantage for use by medical practitioners brings employers into compliance with the requirements of Rule 1910.1030 of the Occupational Safety and Health Administration’s Needlestick Safety and Prevention Act of 2000.
“Some similar products claim they are in full OSHA compliance, while they are not,” said Kirstie Wilson, KLA’s Marketing Manager.
“And, because of the increasing incidence of accidental needle sticks, 21 U.S. states now have laws on the books providing for state sanctions and fines for non-compliance with federal and state rules regulating occupational exposure to blood borne pathogens,” said Wilson. “User safety was the guiding principle in development of the unique K-Shield® Advantage design.”
While the U.S. Centers for Disease Control and Prevention estimate some 800,000 accidental needlestick injuries occur in the U.S. annually, the medical forum www.needlestick.com puts the number at between 600,000 and 1 million annually.
“If these numbers are to be cut substantially, clearly there is a dire need for all facilities that draw blood to require awareness of the availability of ultra-modern needlestick prevention technology for all staff,” commented Wilson.
About Kawasumi Laboratories America
Kawasumi Laboratories America, Inc. (KLA) is a wholly owned subsidiary of Kawasumi Laboratories, Inc.(KL), headquartered in Tokyo, Japan. KL have been providing high quality, cost-effective, medical supplies worldwide since 1957.
Located in Tampa, FL, KLA is the main distribution center for both North and South America. KLA was incorporated in 1991, and recently relocated to a larger facility. KLA is dedicated to maintaining the quality and standards set by the parent company.
Media Contact: Kirstie Wilson
Marketing Manager
813-630-5554 ext. 224
Contact
Kawasumi Laboratories America, Inc.
Kirstie Wilson
813-630-5554
www.kawasumiamerica.com
Kirstie Wilson
813-630-5554
www.kawasumiamerica.com
Contact
Categories